Editor: What To Know
- Fresenius Kabi announced today the availability in the United States of its Glucagon Emergency Kit, an FDA-approved and cost-effective alternative to treat severe hypoglycemic episodes in people with diabetes.
- The bright orange case makes it easy for a patient or caregiver to find it and act quickly.
- To help make the Glucagon Emergency Kit more affordable, there is a co-pay assistance program for patients who qualify.
Fresenius Kabi announced today the availability in the United States of its Glucagon Emergency Kit, an FDA-approved and cost-effective alternative to treat severe hypoglycemic episodes in people with diabetes.
The kit includes Glucagon for Injection 1 mg and a prefilled glass syringe with 1 mL of Sterile Water for Injection, USP.
“For people with diabetes, a severe hypoglycemic episode can occur anywhere and at any time,” said John Ducker, president and CEO of Fresenius Kabi USA. “Our new Glucagon Emergency Kit allows clinicians flexibility and choice for treating patients experiencing severe hypoglycemia. This is another example of Fresenius Kabi’s commitment to providing cost-effective products that deliver life-saving care.”
The Glucagon Emergency Kit is designed to be convenient and easy to use. Patients can carry it with them, so it is available should they experience severe hypoglycemia. The bright orange case makes it easy for a patient or caregiver to find it and act quickly. To help make the Glucagon Emergency Kit more affordable, there is a co-pay assistance program for patients who qualify.
Fresenius Kabi is also making injection training kits available to health care providers to help educate patients. To learn more about the Glucagon Emergency Kit, please visit here.
